King Institute of Preventive Medicine and Research · 1×
×5.42k/333ID
×1.5435/298MM
×2.02k/1kMB
×2.31k/473EPIDE
×1.860/33AMB
Citations per year
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
'26
Countries citing scholars working at AstraZeneca (India)
Since Specialization
Citations
This map shows the geographic impact of research produced by authors working at AstraZeneca (India). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at AstraZeneca (India) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AstraZeneca (India) more than expected).
Fields of papers published by authors at AstraZeneca (India)
This network shows the impact of papers affiliated with AstraZeneca (India) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with AstraZeneca (India) at the time of their publication.
About AstraZeneca (India)
In recent decades, authors affiliated with AstraZeneca (India) have published 245 papers, which have received a total of 6.4k indexed citations . Scholars at this organization have produced 18 papers in Molecular Medicine, 61 papers in Infectious Diseases, 92 papers in Molecular Biology, 38 papers in Epidemiology and 36 papers in Organic Chemistry on the topics of Tuberculosis Research and Epidemiology (51 papers), Cancer therapeutics and mechanisms (33 papers), Mycobacterium research and diagnosis (23 papers), Antibiotic Resistance in Bacteria (18 papers), Biochemical and Molecular Research (17 papers), RNA and protein synthesis mechanisms (14 papers), Bacterial Genetics and Biotechnology (13 papers) and Lung Cancer Treatments and Mutations (12 papers). Their work is cited by papers focused on Infectious Diseases (1.8k citations), Molecular Medicine (435 citations), Molecular Biology (2.4k citations), Epidemiology (1.1k citations) and Applied Microbiology and Biotechnology (60 citations). Authors at AstraZeneca (India) collaborate with scholars in India, United Kingdom and United States and have published in prestigious journals including Antimicrobial Agents and Chemotherapy, PLoS ONE, Organic Process Research & Development, Tetrahedron Letters and SLAS DISCOVERY. Some of AstraZeneca (India)'s most productive authors include Umender Sharma, Parvinder Kaur, Anand Harugeri, Hardik Vasnawala, Radha Krishan Shandil, Sreevalli Sharma, V. Balasubramanian, Dipankar Chatterji, Meenakshi Balganesh and Sheshagiri Gaonkar.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.
Explore institutions with similar magnitude of impact